Lipid Care 360: Optimizing LDL-C Control in 2025 скачать в хорошем качестве

Lipid Care 360: Optimizing LDL-C Control in 2025

This program is supported through an independent educational grant from MSD. It is intended exclusively for healthcare professionals worldwide. In this 30-minute live webinar, leading cardiovascular expert Christopher P. Cannon, MD delivers practical, case-based insights on overcoming therapeutic inertia in lipid management for patients with or at risk of atherosclerotic cardiovascular disease (ASCVD). Drawing on the latest evidence and guideline recommendations, Dr. Cannon examines common barriers—including polypharmacy, risk aversion, and time constraints—that delay treatment intensification. Through real-world patient scenarios, participants will learn evidence-based strategies to confidently escalate lipid-lowering therapy, optimize LDL-C control, and improve long-term cardiovascular outcomes. Accreditation: AffinityCE designates this activity for 0.5 AMA PRA Category 1 Credit™. This interactive session features audience polling, expert-led case discussions, and live Q&A—helping clinicians worldwide sharpen their ability to recognize escalation opportunities, apply LDL-C targets consistently, and address patient concerns to support adherence. Session Highlights Addressing therapeutic inertia: Identify common causes of delayed treatment intensification in ASCVD care. Managing polypharmacy: Balance lipid-lowering therapy with complex medication regimens. Escalation strategies: Apply stepwise, evidence-based approaches when LDL-C remains above goal. Improving adherence: Use communication tools to engage patients and sustain therapy over time. Who Should Watch Cardiologists Endocrinologists/Lipidologists Primary Care Physicians Nurse Practitioners & Physician Assistants Pharmacists Diabetologists Other healthcare professionals managing lipid disorders and ASCVD risk worldwide Presented by Christopher P. Cannon, MD – is a Professor of Medicine at Harvard Medical School, and senior physician in the Cardiovascular Division at Brigham and Women’s Hospital. He worked for 25 years as an investigator in the TIMI Study Group, and is now a member of the Brigham’s Cardiovascular Innovation group, serving as Director of Education. Dr. Cannon has published over 1000 original articles, reviews or book chapters in the field of acute coronary syndromes and prevention and has authored or edited 20 books. He has received numerous awards, including leadership awards from the American College of Cardiology, American Heart Association and National Lipid Association. Learning objectives Apply current cholesterol management guidelines, including LDL-C targets, adherence strategies, and treatment escalation approaches. Design strategies to overcome clinical inertia and streamline access to guideline-recommended lipid-lowering therapies for different patient profiles. Continuing Education Information Please read the full disclosures and accreditation information here before joining the event: https://app.medalleducation.com/event...